Dr. Joseph Tucker is President and CEO of MagicMed Industries Inc., a biotechnology company founded in 2020. The company is focused on creating a library of novel derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, ibogaine, MDMA and LSD. MagicMed’s molecular derivatives library, the Psybrary™️, is intended to be an essential building block from which industry partners can develop new patented products. MagicMed’s mission is to unlock the full potential of psychedelic-derived medicines. The company is focused on the discovery and development of novel drug candidates, structurally related to classic psychedelics but with improved pharmaceutical characteristics.
Want to stay up-to-date on the latest #entrepreneur podcasts and news? Subscribe to our bi-weekly newsletter